INTERVAL DEBULKING OF OVARIAN-CANCER - AN INTERIM MEASURE

被引：16

作者：

BEREK, JS

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1995年 / 332卷 / 10期

关键词：

D O I：

10.1056/NEJM199503093321010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：675 / 677

页数：3

共 13 条

[1]

BEREK JS, 1983, OBSTET GYNECOL, V61, P189

[2]

BEREK JS, 1984, OBSTET GYNECOL, V64, P207

[3]

BEREK JS, 1994, PRACTICAL GYNECOLOGI, P327

[4] THE IMPACT OF SUBSPECIALTY TRAINING ON THE MANAGEMENT OF ADVANCED OVARIAN-CANCER [J].

EISENKOP, SM ;

SPIRTOS, NM ;

MONTAG, TW ;

NALICK, RH ;

WANG, HJ .

GYNECOLOGIC ONCOLOGY, 1992, 47 (02) :203-209

[5] THE INFLUENCE OF TUMOR GRADE, DISTRIBUTION, AND EXTENT OF CARCINOMATOSIS IN MINIMAL RESIDUAL STAGE-III EPITHELIAL OVARIAN-CANCER AFTER OPTIMAL PRIMARY CYTOREDUCTIVE SURGERY [J].

FARIASEISNER, R ;

TENG, F ;

OLIVEIRA, M ;

LEUCHTER, R ;

KARLAN, B ;

LAGASSE, LD ;

BEREK, JS .

GYNECOLOGIC ONCOLOGY, 1994, 55 (01) :108-110

[6]

GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727

[7]

GRIFFITHS CT, 1975, NCI MONOGRAPH, V42

[8]

HACKER NF, 1983, OBSTET GYNECOL, V61, P413

[9] TREATMENT RESULTS - GYNECOLOGICAL CANCER - THE ANNUAL-REPORT [J].

PETTERSSON, F .

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1991, 36 (01) :1-3

[10] NEOADJUVANT CHEMOTHERAPY FOR ADVANCED OVARIAN-CANCER [J].

SCHWARTZ, PE ;

CHAMBERS, JT ;

MAKUCH, R .

GYNECOLOGIC ONCOLOGY, 1994, 53 (01) :33-37

← 1 2 →